Enable Injections Advances Drug Delivery
Enable Injections is a startup launched with intellectual property from Cincinnati Children’s. The company has gone on to advance drug delivery with its wearable enFuse® device, which delivers large-volume medications subcutaneously—replacing traditional IV therapies. Products from this startup have demonstrated proven market impact, earning adoption from leading pharmaceutical partners and addressing a critical need for more patient-friendly, cost-effective drug delivery solutions.
Backed by over $314 million in funding—including a $215 million Series C round led by Magnetar Capital and supported by prominent investors like GCM Grosvenor and CincyTech—Enable Injections has become the tri-state's best-funded startup. Its scalable technology, strong market traction, and growing demand position the company as a standout success in healthcare innovation, exemplifying how Cincinnati Children’s transforms discovery into real-world impact. Learn more about the origins of Enable.
Visit Cincinnati Children's Science Blog to learn more about the origins of Enable.
